Serum thyroglobulin levels after thyroxine withdrawal in patients with low risk papillary thyroid carcinoma

Thyroid

Volumn 10, Issue 2, 2000, Pages 165-169

  Sisson, J C ^a   Thompson, N W ^a   Giordano, T J ^a   England, B G ^a   Normolle, D P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROXINE;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA;

EID: 0033997647     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.165     Document Type: Article

References (28)

1. Aschraft MV, Van Herle AJ 1981 The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow up study of patients with treated differentiated thyroid cancer. Am J Med 71:806-814.
2. Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A 1985 Diagnostic value of single term thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf). 23:405-411.
3. Black EG, Sheppard MC, Hoffenberg R 1987 Serial serum thyroglobulin measurement in the management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 27:115-120.
4. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ 1994 Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105.
5. Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C, Pinchera A 1987 Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888-1891.
6. Maxon HR III 1993 The role of 131-I in the treatment of thyroid cancer. Thyroid Today 16:1-9.
7. Clark OH, Hoelting T 1994 Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans. Thyroid 4:501-505.
8. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80:1488-1492.
9. Mazzaferri EL 1995 Treating high thyroglobulin with radioiodine: A magic bullet or a shot in the dark? [editorial] J Clin Endocrinol Metab 80:1485-1487.
10. Schlumberger M, Mancusi F, Baudin E, Pacini F 1997 131-I therapy for elevated thyroglobulin levels. Thyroid 7:273-276.
11. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C 1988 Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays. J Nucl Med 29:1790-1794.
12. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O'Sullivan B 1997 A comparison of different staging systems. Predictability of patient outcome. Thyroid carcinoma as an example. Cancer 79:2414-2423.
13. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058.
14. McDougall IR 1997 131-I Treatment of 131-I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: What is being treated? Thyroid 7:669-672.
15. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID 1998 Therapeutic controversy. The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 83:4195-4203.
16. Schneider AB, Line BR, Goldman JM, Robbins J 1981 Sequential serum thyroglobulin determinations, 131-I scans and 131-I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab 53:1199-1206.
17. Lakshmanan M, Schaffer A, Robbins J, Reynolds J, Norton J 1988 A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer. Clin Nucl Med 13:866-868.
18. Baudin E, Schlumberger M, Lubroso J, Travagli JP, Caillou B, Parmentier C 1996 Octreotide scintigraphy in patients with differentiated thyroid carcinoma: Contribution for patients with negative radioiodine scan. J Clin Endocrinol Metab 81:2541-2544.
19. Sherman SI, Brierly JD, Sperling M, et al 1998 Prospective multicenter study of thyroid carcinoma treatment. Initial analysis of staging and outcome. Cancer 83:1012-1021.
20. Cady B 1998 Staging of thyroid carcinoma [editorial]. Cancer 83:844-847.
21. Hermanek P, Sobin LH 1987 UICC: TNM Classification of Malignant Tumours. Fourth revised edition. Springer-Verlag, New York, p 32.
22. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127.
23. Sampson RJ, Oka H, Key CR, Buncher CR, Iijima S 1970 Metastases from occult thyroid carcinoma. Cancer 25:803-811.
24. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery 112:1139-1147.
25. Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C, Schlumberger M 1998 Combination of radioiodine (131-I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 83: 2675-2680.
26. Grebe SKG, Hay ID 1996 Thyroid cancer nodal metastases. Surg Oncol Clinic North Am 5:43-63.
27. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424.
28. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.